+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Sunovion Pharmaceuticals Inc - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 27 Pages
  • September 2022
  • GlobalData
  • Sunovion
  • ID: 4050704
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Sunovion Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description - A detailed description of the company's operations and business divisions.
  • Corporate strategy - The publisher's summarization of the company's business strategy.
  • SWOT analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives' employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

Sunovion Pharmaceuticals Inc (Sunovion), a subsidiary of Sumitomo Dainippon Pharmaceutical Co Ltd, is a research-based pharmaceutical company. It discovers, develops, and marketize therapeutic products that focus on the treatment of the central nervous system and respiratory disorders. Its major products include eslicarbazepine acetate tablets, lurasidone HCl tablets, eszopiclone tablets, glycopyrrolate inhalation solution and levalbuterol tartrate inhalation aerosol. The company's product candidates are intended for the treatment of schizophrenia, neuropathic pain, bipolar depression, treatment-resistant depression, agitation in Alzheimer's disease, and Parkinson's disease, among others. It has partnerships with various pharmaceutical companies such as Psychogenics and others. Sunovion is headquartered in Marlborough, Massachusetts, the US.

Sunovion Pharmaceuticals Inc Key Recent Developments

  • Oct 12, 2021: Sunovion Answers is named a J.D. Power 2021 Certified Customer Service Program

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors' business structure and strategies with the publisher's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • Sunovion Pharmaceuticals Inc - Key Facts
  • Sunovion Pharmaceuticals Inc - Key Employees
  • Sunovion Pharmaceuticals Inc - Key Employee Biographies
  • Sunovion Pharmaceuticals Inc - Major Products and Services
  • Sunovion Pharmaceuticals Inc - History
  • Sunovion Pharmaceuticals Inc - Company Statement
  • Sunovion Pharmaceuticals Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Sunovion Pharmaceuticals Inc - Business Description
  • Sunovion Pharmaceuticals Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Sunovion Pharmaceuticals Inc - Strengths
  • Sunovion Pharmaceuticals Inc - Weaknesses
  • Sunovion Pharmaceuticals Inc - Opportunities
  • Sunovion Pharmaceuticals Inc - Threats
  • Sunovion Pharmaceuticals Inc - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • Sunovion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
  • Sunovion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
  • Sunovion Pharmaceuticals Inc, Recent Deals Summary
Section 4 - Company’s Recent Developments
  • Oct 12, 2021: Sunovion Answers is named a J.D. Power 2021 Certified Customer Service Program
Section 5 - Appendix
  • Methodology
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Sunovion Pharmaceuticals Inc, Key Facts
  • Sunovion Pharmaceuticals Inc, Key Employees
  • Sunovion Pharmaceuticals Inc, Key Employee Biographies
  • Sunovion Pharmaceuticals Inc, Major Products and Services
  • Sunovion Pharmaceuticals Inc, History
  • Sunovion Pharmaceuticals Inc, Other Locations
  • Sunovion Pharmaceuticals Inc, Subsidiaries
  • Sunovion Pharmaceuticals Inc, Key Competitors
  • Sunovion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
  • Sunovion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
  • Sunovion Pharmaceuticals Inc, Recent Deals Summary
List of Figures
  • Sunovion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
  • Sunovion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2016 to YTD 2022

Companies Mentioned

A selection of companies mentioned in this report includes:

  • OptiNose Inc
  • Acadia Pharmaceuticals Inc
  • Pharmagenesis Inc
  • NeuroGeneration Inc
  • Curemark LLC
  • Aeolus Pharmaceuticals Inc